Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.0080 AUD
Change Today 0.00 / 0.00%
Volume 1.0M
As of 9:01 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

analytica ltd (ALT) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/25/14 - A$0.04
52 Week Low
07/16/15 - A$0.0070
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ANALYTICA LTD (ALT)

Related News

No related news articles were found.

analytica ltd (ALT) Related Businessweek News

No Related Businessweek News Found

analytica ltd (ALT) Details

Analytica Limited design, develops, and supplies medical devices in Australia. The company’s lead products include PeriCoach, a perineometer device to assist women and their clinicians in treatment of stress urinary incontinence; and ELF2, a medical device that assists neurologist and rehabilitates treatment of muscular spasticity. It also offers the AutoStart Burette Infusion System, which automatically restarts the delivery of intravenous fluid once the burette has dispensed its predetermined amount of liquid or drug. The company is based in Brisbane, Australia.

analytica ltd (ALT) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: A$210.0K
Executive Chairman, Member of Audit & Risk Ma...
Total Annual Compensation: A$75.0K
Chief Financial Officer, Executive Director, ...
Total Annual Compensation: A$50.0K
Compensation as of Fiscal Year 2014.

analytica ltd (ALT) Key Developments

Analytica Ltd. Reports Earnings Results for the Half Year Ended December 31, 2014

Analytica Ltd. reported earnings results for the half year ended December 31, 2014. For the period, the company reported sales revenue of AUD 4,859. Loss before income tax was AUD 1,923,938 compared to AUD 1,373,021 a year ago. Loss for the period was AUD 1,923,938 compared to AUD 1,373,021 a year ago. Basic and diluted loss per share was 0.21 cents compared to 0.23 cents a year ago. Net cash used in operating activities of AUD 1,865,112 compared to AUD 977,915 a year ago. Purchase of proerty, plant and equipment was AUD 42,102 compared to AUD 3,973 a year ago.

Analytica Ltd., Annual General Meeting, Nov 27, 2014

Analytica Ltd., Annual General Meeting, Nov 27, 2014., at 17:00 E. Australia Standard Time. Location: Endeavour 1 Room, Level 1, Christie Corporate, 320 Adelaide Street. Agenda: To receive and consider the financial report, director's report and independent audit report for the company and its controlled entities for the financial year ended 30 June 2014; to consider the adoption of the remuneration report; to approve Board changes; to approve ratification of April and October 2014 Placement; to consider approval of enhanced placement capacity.

Analytica Ltd Announces Composition of its Clinical Advisory Boards in Australia and the United States

Analytica Ltd. announced the composition of its Clinical Advisory Boards in Australia and the United States. Australian CAB consists of: Professor Ajay Rane: Director of Urogynaecology, Townsville Hospital, Director of the Mater Pelvic Research and Education Unit at the Townsville Mater Hospital, Professor of Obstetrics and Gynaecology at James Cook University, Townsville. Dr. Ailsa Wilson Edwards: Urologic surgeon at Continence Matters, Adelaide. Dr. Margaret Sherburn: Senior lecturer, Melbourne University, APA Continence and Women's Health Specialist Physiotherapist, Clinical Head and Manager, Physiotherapy, The Royal Women's Hospital, Melbourne. Dr. Pauline Chiarelli: Associate Professor and Program Convenor for the Discipline of Physiotherapy at Newcastle University (Australia). Kay Talbot: Urological/Incontinence Nurse at Australian Urology Associates (AUA). Kay was a founding member of the Victorian Urological Nurses Society, and the inaugural president and meeting convenor of the Australia and New Zealand Urological Nurses Society. Marietta Mehanni: Pelvic Floor First Ambassador, Australian Fitness Network Ambassador, Fitness Gymstick International Program Coordinator and Master Trainer. The US CAB consists of: Dr. G Willy Davila: Chairman of the Department of Gynaecology and Head of the Section of Urogynaecology and Reconstructive Pelvic Surgery at Cleveland Clinic. Dr. Elizabeth Mueller: Associate Professor, Division Director, Female Pelvic Medicineand Reconstructive Surgery, Fellowship Program Director, Female Pelvic Medicine and Reconstructive Surgery, Medical Director Urogynaecology, Female Pelvic Medicine and Reconstructive Surgery, Urology. Dr. Francie Bernier: RNC Dr. Bernier is on the Nursing Faculty at Shenandoah University in Winchester, Virginia. Dr. Beth Shelly: Pelvic Physical Therapist Educator. Dawn Sandalcidi: Physiotherapist specialising in: pelvic muscle dysfunction (incontinence and pain), orthopedic manual therapy, and TMJ treatment. Mary Drill: Fitness Trainer, Master Trainer and Consultant at Body Mechanics by Drill.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALT:AU A$0.01 AUD 0.00

ALT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALT.
View Industry Companies

Industry Analysis


Industry Average

Valuation ALT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.5x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANALYTICA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at